Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Cosmos Health Inc COSM

Cosmos Health Inc. is a global healthcare company. The Company owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It distributes a line of pharmaceuticals... see more

Recent & Breaking News (NDAQ:COSM)

Cosmos Health Launches First Sky Premium Life Nutritional Supplement Products on Amazon in the United States

Accesswire August 25, 2022

Cosmos Health Reports 202.42 % Increase in Adjusted EBITDA and Positive Operating Income for the First Half of 2022

Accesswire August 22, 2022

Cosmos Holdings Announces Name Change to Cosmos Health, Reflecting Company's Evolution into an Innovative Global Healthcare Group, Driven by One Purpose: Improving People's Lives

Accesswire July 29, 2022

Cosmos Holdings Appoints Dr. Manfred Ziegler to its Advisory Board

Accesswire July 22, 2022

Cosmos Holdings Announces Agreement to Acquire Cana Laboratories, a Legacy European Pharmaceutical Company Established in 1928; Vertically Integrating its Manufacturing and R&D Capabilities and Expanding its Product Pipeline with New Brands

Accesswire July 20, 2022

Cosmos Holdings Subsidiary Granted Full Membership in PAGB, A UK-based Consumer Healthcare Association

Accesswire July 12, 2022

Cosmos Holdings Appoints Dr. Panagiotis Zoumpoulakis to its Advisory Board

Accesswire July 8, 2022

Cosmos Holdings to Acquire LIFE NLB Portfolio of Bone Health Products that Target the Gastrointestinal Microbiome

Accesswire July 6, 2022

Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders

Accesswire June 30, 2022

Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon in the United States

Accesswire June 2, 2022

Cosmos Holdings Reports 12.5% Increase in Revenue, 88.9% Increase in Gross Profit and Achieves Profitability for the First Quarter of 2022

Accesswire May 18, 2022

Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon Canada

Accesswire May 5, 2022

Cosmos Holdings Appoints Finance Veteran Dr. Anastasios Aslidis to the Board of Directors and as a Member of the Board's Audit Committee

Accesswire May 3, 2022

Cosmos Holdings Reports Continued Revenue Growth and Achieves $3.3 Million of Adjusted EBITDA for the Fiscal Year 2021

Accesswire April 19, 2022

Cosmos Holdings Launches Mediterranation, a New Premium Nutritional Supplements Line

Accesswire April 12, 2022

Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon Singapore

Accesswire April 5, 2022

Cosmos Holdings Launches Proprietary Sky Premium Life Brainlit Supplement for Brain Health

Accesswire March 31, 2022

Cosmos Holdings Launches Proprietary Sky Premium Life Prostatium Supplement for Prostate Health

Accesswire March 28, 2022

Cosmos Holdings to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest

Accesswire March 24, 2022

Cosmos Holdings CEO Provides Letter to Shareholders

Accesswire March 23, 2022